Financials data is unavailable for this security.
View more
Year on year Apyx Medical Corp grew revenues 17.61% from 44.51m to 52.35m while net income improved from a loss of 23.18m to a smaller loss of 18.71m.
Gross margin | 61.90% |
---|---|
Net profit margin | -58.08% |
Operating margin | -52.34% |
Return on assets | -44.55% |
---|---|
Return on equity | -110.50% |
Return on investment | -58.21% |
More ▼
Cash flow in USDView more
In 2023, Apyx Medical Corp increased its cash reserves by 328.30%, or 33.46m. Cash Flow from Financing totalled 32.17m or 61.45% of revenues. In addition the company used 5.25m for operations while cash from investing totalled 6.73m.
Cash flow per share | -0.8031 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4257 |
---|---|
Tangible book value per share | 0.4257 |
More ▼
Balance sheet in USDView more
Current ratio | 5.33 |
---|---|
Quick ratio | 4.45 |
Total debt/total equity | 2.28 |
---|---|
Total debt/total capital | 0.693 |
More ▼